Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Dronabinol has preferential antileukemic activity in acute lymphoblastic and myeloid leukemia with lymphoid differentiation patterns.

Kampa-Schittenhelm KM, Salitzky O, Akmut F, Illing B, Kanz L, Salih HR, Schittenhelm MM.

BMC Cancer. 2016 Jan 16;16:25. doi: 10.1186/s12885-015-2029-8.

2.

Rapamycin, an mTOR inhibitor, induced apoptosis via independent mitochondrial and death receptor pathway in retinoblastoma Y79 cell.

Wang YD, Su YJ, Li JY, Yao XC, Liang GJ.

Int J Clin Exp Med. 2015 Jul 15;8(7):10723-30. eCollection 2015.

3.
4.
5.

Epigenetic Regulation of Immunological Alterations Following Prenatal Exposure to Marijuana Cannabinoids and its Long Term Consequences in Offspring.

Zumbrun EE, Sido JM, Nagarkatti PS, Nagarkatti M.

J Neuroimmune Pharmacol. 2015 Jun;10(2):245-54. doi: 10.1007/s11481-015-9586-0. Epub 2015 Jan 25. Review.

6.

Critical appraisal of the potential use of cannabinoids in cancer management.

Cridge BJ, Rosengren RJ.

Cancer Manag Res. 2013 Aug 30;5:301-13. doi: 10.2147/CMAR.S36105. eCollection 2013. Review.

7.

Targeting cannabinoid receptors as a novel approach in the treatment of graft-versus-host disease: evidence from an experimental murine model.

Pandey R, Hegde VL, Nagarkatti M, Nagarkatti PS.

J Pharmacol Exp Ther. 2011 Sep;338(3):819-28. doi: 10.1124/jpet.111.182717. Epub 2011 Jun 14.

8.

Caveolin-1 mediates Fas-BID signaling in hyperoxia-induced apoptosis.

Zhang M, Lee SJ, An C, Xu JF, Joshi B, Nabi IR, Choi AM, Jin Y.

Free Radic Biol Med. 2011 May 15;50(10):1252-62. doi: 10.1016/j.freeradbiomed.2011.02.031. Epub 2011 Mar 5.

9.

β-Elemene piperazine derivatives induce apoptosis in human leukemia cells through downregulation of c-FLIP and generation of ROS.

Yu Z, Wang R, Xu L, Xie S, Dong J, Jing Y.

PLoS One. 2011 Jan 25;6(1):e15843. doi: 10.1371/journal.pone.0015843.

10.

Do cannabinoids have a therapeutic role in transplantation?

Nagarkatti M, Rieder SA, Hegde VL, Kanada S, Nagarkatti P.

Trends Pharmacol Sci. 2010 Aug;31(8):345-50. doi: 10.1016/j.tips.2010.05.006. Epub 2010 Jun 28. Review.

11.

Cannabinoids as novel anti-inflammatory drugs.

Nagarkatti P, Pandey R, Rieder SA, Hegde VL, Nagarkatti M.

Future Med Chem. 2009 Oct;1(7):1333-49. doi: 10.4155/fmc.09.93. Review.

12.

Use of cannabinoids as a novel therapeutic modality against autoimmune hepatitis.

Pandey R, Hegde VL, Singh NP, Hofseth L, Singh U, Ray S, Nagarkatti M, Nagarkatti PS.

Vitam Horm. 2009;81:487-504. doi: 10.1016/S0083-6729(09)81019-4. Review.

13.

Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression.

Rieder SA, Chauhan A, Singh U, Nagarkatti M, Nagarkatti P.

Immunobiology. 2010 Aug;215(8):598-605. doi: 10.1016/j.imbio.2009.04.001. Epub 2009 May 20. Review.

14.

The endocannabinoid system as an emerging target of pharmacotherapy.

Pacher P, Bátkai S, Kunos G.

Pharmacol Rev. 2006 Sep;58(3):389-462. Review.

Supplemental Content

Support Center